The Cytotoxic Cell Studies Group has made significant advances in understanding the molecular mechanism of natural killer (NK) cell function by examining the role of a novel gene, Nktr, in the tumor recognition/killing mechanism of NK cells. The crucial role of the NK-TR protein in target cell recognition/killing was demonstrated by inhibiting NK-TR expression in primary human and mouse NK cells with a retroviral vector producing antisense Nktr RNA. Experiments with freshly isolated human and mouse NK cells have demonstrated a dramatic loss of NK activity relative to control retrovirus infections. Although NK cells are the only freshly isolated cell to express NK-TR, several non-NK cell lines were shown to be positive. A burst of NK-TR expression was observed when the human HL-60 cell line was induced to differentiate into granulocytes. This finding lead to the study of the role of the NK-TR in the process of hematopoietic differentiation. Antisense Nktr transfectants of the HL-60 cell line were no longer able to differentiate into granulocytes. The possible involvement of NK-TR in pre-mRNA splicing has been strengthened by our discovery of an NK-TR related protein (CARS-Cyp) that is expressed in every tissue and cell type examined with the exception of NK cells. The rat homolog of CARS-Cyp has been identified as a nuclear protein associated with splicing complexes. Our current studies are directed towards defining NK-TR function in cytotoxic cells and developing gene knockout mice. Mice heterozygous for an Nktr null mutation have been generated, and are currently being bred to produce homozygous Nktr -deficient mice. The Nktr promoter has been analyzed, and it does not repre-sent an NK cell-specific promotor. The NK specificity of NK-TR expression was shown to be controlled at the level of pre-mRNA splicing. We have recently cloned two members of the Ly-49 family that are expressed on murine NK cells. Ly-49G2, which appears to recognize the class I molecules H2-Dd and/ or H2-Ld and Ly-49D whose class I recognition is under study. The previously studied Ly-49 family members are inhibitory receptors that recognize MHC class I, however, Ly-49D has been shown to represent

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Intramural Research (Z01)
Project #
1Z01BC010013-01
Application #
2463813
Study Section
Special Emphasis Panel (LEI)
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Name
National Cancer Institute Division of Basic Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Belanger, S; Tai, L-H; Anderson, S K et al. (2008) Ly49 cluster sequence analysis in a mouse model of diabetes: an expanded repertoire of activating receptors in the NOD genome. Genes Immun 9:509-21
Anderson, S K (2006) Transcriptional regulation of NK cell receptors. Curr Top Microbiol Immunol 298:59-75
Makrigiannis, A P; Patel, D; Goulet, M-L et al. (2005) Direct sequence comparison of two divergent class I MHC natural killer cell receptor haplotypes. Genes Immun 6:71-83
Anderson, S K; Dewar, K; Goulet, M-L et al. (2005) Complete elucidation of a minimal class I MHC natural killer cell receptor haplotype. Genes Immun 6:481-92
Saleh, Ali; Davies, Gareth E; Pascal, Veronique et al. (2004) Identification of probabilistic transcriptional switches in the Ly49 gene cluster: a eukaryotic mechanism for selective gene activation. Immunity 21:55-66
Makrigiannis, Andrew P; Rousselle, Etienne; Anderson, Stephen K (2004) Independent control of Ly49g alleles: implications for NK cell repertoire selection and tumor cell killing. J Immunol 172:1414-25
Makrigiannis, Andrew P; Anderson, Stephen K (2003) Regulation of natural killer cell function. Cancer Biol Ther 2:610-6
Mason, Llewellyn H; Willette-Brown, Jami; Anderson, Stephen K et al. (2003) Receptor glycosylation regulates Ly-49 binding to MHC class I. J Immunol 171:4235-42
Makrigiannis, A P; Anderson, S K (2000) Ly49 gene expression in different inbred mouse strains. Immunol Res 21:39-47
Makrigiannis, A P; Etzler, J; Winkler-Pickett, R et al. (2000) Identification of the Ly49L protein: evidence for activating counterparts to inhibitory Ly49 proteins. J Leukoc Biol 68:765-71

Showing the most recent 10 out of 15 publications